The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CLLK.F | -38.91% | -90.16% | -36.94% | -84% |
| S&P | +13.19% | +87.83% | +13.42% | +163% |
BICO Group AB is a bioconvergence company, which engages in the provision of technologies, products, and services to create, understand, and master biology. It operates through the Laboratory Solutions and Bioautomation segments. The Laboratory Solutions segment consists of the bioprinting and biosciences business. The Bioautomation segment comprises of the SCIENION along with subsidiary Cellenion, Ginolis, and QInstruments. The company was founded by Erik Paul Gatenholm and Hector Daniel Martinez Avila in 2016 and is headquartered in Gothenburg, Sweden.
No news articles found for BICO Group.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $40.65M | -14.5% |
| Gross Profit | $17.41M | -0.8% |
| Gross Margin | 42.83% | 5.9% |
| Market Cap | $141.15M | -64.3% |
| Market Cap / Employee | $0.23M | 0.0% |
| Employees | 602 | 0.0% |
| Net Income | -$116.37M | -390.0% |
| EBITDA | $2.35M | -19.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $131.90M | 105.8% |
| Accounts Receivable | $38.67M | -7.0% |
| Inventory | 24.6 | -12.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $24.80M | -86.0% |
| Short Term Debt | $113.23M | 975.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -28.33% | -11.2% |
| Return On Invested Capital | -4.40% | 1.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$3.77M | -222.2% |
| Operating Free Cash Flow | -$3.23M | -177.9% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.73 | 0.80 | 1.00 | 0.55 | -61.24% |
| Price to Sales | 1.02 | 1.15 | 1.56 | 0.91 | -39.47% |
| Price to Tangible Book Value | -19.58 | -203.28 | 27.03 | -179.36 | 826.49% |
| Price to Free Cash Flow TTM | 19.29 | 10.78 | 11.25 | 8.86 | -75.70% |
| Enterprise Value to EBITDA | 26.62 | -178.03 | -52.11 | 65.76 | -55.75% |
| Free Cash Flow Yield | 5.2% | 9.3% | 8.9% | 11.3% | 311.50% |
| Return on Equity | -2.6% | -10.6% | -15.0% | -57.3% | 101.39% |
| Total Debt | $159.60M | $140.18M | $147.55M | $138.02M | -26.24% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
